Abstract
p50 is a member of the NF-kappaB family known to be involved in endometriosis. To gain insight into the roles of p50 in the development of endometriosis, we crosstransplanted endometrial fragments from p50 knockout mice to wild-type mice and vice versa, and also autotransplanted the fragments within the knockout and wild-type mice, inducing endometriosis. We then evaluated the size of the endometrial implants, and immunoreactivity to phosphorylated p65 (p-p65), PKCepsilon and TRPV1 in ectopic and eutopic endometrium as well as in vagina. We found that p50 deletion significantly reduces the size of endometrial implants. The immunoreactivity to p-p65 and PKCepsilon, but not TRPV1, was reduced in endometrial implants in p50 knockout mice. Deletion of p50 significantly reduced p-p65 and PKCepsilon, but not TRPV1, expression in eutopic endometrium and vagina. It also disrupts NF-kappaB activation and PKCepsilon expression in eutopic and vagina, suggesting the role of NF-kappaB in regulating PKCepsilon, which plays an important role in nociception. These data show that p50 is involved in the development of endometriosis and may be a promising therapeutic target.
Author supplied keywords
Cite
CITATION STYLE
Lu, Y., Sun, Q., Zheng, Y., Liu, X., Geng, J. G., & Guo, S. W. (2011). The role of nuclear factor-kappa-B p50 subunit in the development of endometriosis. Frontiers in Bioscience - Elite, 3 E(2), 591–603. https://doi.org/10.2741/e272
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.